Pharmaceuticals
Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada
D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections.
Europe, Israel, and the medical record of a nation - opinion
How Evogene is changing the future for the pharma and agriculture markets
Taking too many medications may harm older adults, study warns
IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience
The meeting at HP Indigo focused on “full-scope companies,” multinationals that combine R&D, manufacturing, operations, exports, and global support in Israel.
A Passover tribute: Kindness from a Jerusalem neighborhood pharmacy
Every year as Seder approaches, we all look for inspiration in how to make our Seder even richer than the year before.
New immigrant pharmacists face discrimination, lack of gov't support despite professional shortage
Mazarsky's comments follow the state's reluctance to accept over 170 qualified pharmacists who are intending to make aliyah in the coming year and have opened files with the Jewish Agency.
EcoSupp listens, learns, and delivers
Israeli health officials call for sanctions on anti-vaxxers as flu morbidity rate rises
Only 17% of Israelis have been vaccinated; health fund CEOs are divided over sanctions versus accessibility.
Israel's biotech moment: How science, data, and geopolitics are converging - opinion
Why now Is the time to invest in a deeply built, undervalued market
From Auschwitz to Dachau: How a pharmacist became central to Nazi camp medical crimes - study
The authors explore how pharmaceutical logistics and networks enabled neglect, experimentation, and killings in the camp medical system.
EU Council and Parliament reach agreement to overhaul drug rules, speed patient access
The agreement grants companies launching new medicines eight years of data protection for trial results and one year of market protection.
Israeli gas sensor spots ‘mirror’ molecules, opening path to breath-based diagnostics
By detecting subtle structural differences in volatile compounds, the sensors could power non-invasive breath tests for diseases such as lung cancer or diabetes.
Novo Nordisk advances amycretin to late-stage trial after positive diabetes weight-loss results
Novo Nordisk’s experimental drug amycretin shows strong results in its mid-stage trial, helping type 2 diabetes patients lose up to 14.5% of their body weight.
